Drugs / Mailuo Shutong Pills
Mailuo Shutong Pills
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT07258381 | Dec 2025 → Dec 2026 expected | chronic ulcer of skin | Peking University Third Hospital | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Mailuo Shutong Pills | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07258381 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “Mailuo Shutong Pills are a Chinese patent medicine approved for market release by the China Food and Drug Administration (CFDA) in 2009.” NCT07258381 ↗ |
| Route | Oral | “oral administration of Maoluo Shutong Pills was administered for 2 weeks” NCT07258381 ↗ |